Antigen Presentation and the Ubiquitin-Proteasome System in Host-Pathogen Interactions

Advances in Immunology

Volumn 92, Issue , 2006, Pages 225-305

  Loureiro, Joana ^a   Ploegh, Hidde L ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; CD4 ANTIGEN; CD8 ANTIGEN; CELL SURFACE RECEPTOR; CORE PROTEIN; CYTOKINE; EPITOPE; GLYCOPEPTIDASE; HLA E ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SIGNAL PEPTIDASE; UBIQUITIN PROTEIN LIGASE; VIRUS PROTEIN;

ANTIGEN PRESENTATION; APOPTOSIS; BACTERIAL CHROMOSOME; CATALYSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOSOL; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; ENDOPLASMIC RETICULUM; EUKARYOTIC CELL; GENE MUTATION; GENOME; HEAVY CHAIN; HEPATITIS C VIRUS; HERPES VIRUS; HOST PARASITE INTERACTION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN PROCESSING; QUALITY CONTROL; REVIEW; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

ANIMALS; ANTIGEN PRESENTATION; HUMANS; INFECTION; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 33751506565     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(06)92006-9     Document Type: Review

References (468)

1. Adams J. The proteasome: Structure, function, and role in the cell. Cancer Treat. Rev. 29 Suppl. 1 (2003) 3-9
2. Ahn K., Angulo A., Ghazal P., Peterson P.A., Yang Y., and Fruh K. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc. Natl. Acad. Sci. USA 93 20 (1996) 10990-10995
3. Ahn K., Gruhler A., Galocha B., Jones T.R., Wiertz E.J., Ploegh H.L., Peterson P.A., Yang Y., and Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6 5 (1997) 613-621
4. Aiken C., Konner J., Landau N.R., Lenburg M.E., and Trono D. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76 5 (1994) 853-864
5. Ait-Goughoulte M., Hourioux C., Patient R., Trassard S., Brand D., and Roingeard P. Core protein cleavage by signal peptide peptidase is required for hepatitis C virus-like particle assembly. J. Gen. Virol. 87 Pt. 4 (2006) 855-860
6. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 4 (2006) 783-801
7. Alam S.M., Travers P.J., Wung J.L., Nasholds W., Redpath S., Jameson S.C., and Gascoigne N.R. T-cell-receptor affinity and thymocyte positive selection. Nature 381 6583 (1996) 616-620
8. Alcami A. Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 3 1 (2003) 36-50
9. Alcami A., and Koszinowski U.H. Viral mechanisms of immune evasion. Trends Microbiol. 8 9 (2000) 410-418
10. Ambagala A.P., Solheim J.C., and Srikumaran S. Viral interference with MHC class I antigen presentation pathway: The battle continues. Vet. Immunol. Immunopathol. 107 1-2 (2005) 1-15
11. Amerik A.Y., and Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta 1695 1-3 (2004) 189-207
12. Andersen M.H., Schrama D., Thor Straten P., and Becker J.C. Cytotoxic T cells. J. Invest. Dermatol. 126 1 (2006) 32-41
13. Andre P., Groettrup M., Klenerman P., de Giuli R., Booth Jr. B.L., Cerundolo V., Bonneville M., Jotereau F., Zinkernagel R.M., and Lotteau V. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses. Proc. Natl. Acad. Sci. USA 95 22 (1998) 13120-13124
14. Andresson T., Sparkowski J., Goldstein D.J., and Schlegel R. Vacuolar H(+)-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein. J. Biol. Chem. 270 12 (1995) 6830-6837
15. Apcher G.S., Heink S., Zantopf D., Kloetzel P.M., Schmid H.P., Mayer R.J., and Kruger E. Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits. FEBS Lett. 553 1-2 (2003) 200-204
16. Ardley H.C., and Robinson P.A. E3 ubiquitin ligases. Essays Biochem. 41 (2005) 15-30
17. Arnon T.I., Achdout H., Levi O., Markel G., Saleh N., Katz G., Gazit R., Gonen-Gross T., Hanna J., Nahari E., Porgador A., Honigman A., et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6 5 (2005) 515-523
18. Babst M., Odorizzi G., Estepa E.J., and Emr S.D. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 1 3 (2000) 248-258
19. Backstrom E., Kristensson K., and Ljunggren H.G. Activation of natural killer cells: Underlying molecular mechanisms revealed. Scand. J. Immunol. 60 1-2 (2004) 14-22
20. Balakirev M.Y., Jaquinod M., Haas A.L., and Chroboczek J. Deubiquitinating function of adenovirus proteinase. J. Virol. 76 12 (2002) 6323-6331
21. Banks L., Pim D., and Thomas M. Viruses and the 26S proteasome: Hacking into destruction. Trends Biochem. Sci. 28 (2003) 452-459
22. Barel M.T., Ressing M., Pizzato N., van Leeuwen D., Le Bouteiller P., Lenfant F., and Wiertz E.J. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. J. Immunol. 171 12 (2003) 6757-6765
23. Barel M.T., Pizzato N., Le Bouteiller P., Wiertz E.J., and Lenfant F. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation. Int. Immunol. 18 1 (2006) 173-182
24. Barretto N., Jukneliene D., Ratia K., Chen Z., Mesecar A.D., and Baker S.C. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J. Virol. 79 24 (2005) 15189-15198
25. Barry M., and Fruh K. Viral modulators of cullin RING ubiquitin ligases: Culling the host defense. Sci. STKE 2006 335 (2006) pe21
26. Bartee E., Mansouri M., Hovey Nerenberg B.T., Gouveia K., and Fruh K. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J. Virol. 78 3 (2004) 1109-1120
27. Bays N.W., and Hampton R.Y. Cdc48-Ufd1-Npl4: Stuck in the middle with Ub. Curr. Biol. 12 10 (2002) R366-R371
28. Bays N.W., Gardner R.G., Seelig L.P., Joazeiro C.A., and Hampton R.Y. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation. Nat. Cell Biol. 3 1 (2001) 24-29
29. Beissert S., Schwarz A., and Schwarz T. Regulatory T cells. J. Invest. Dermatol. 126 1 (2006) 15-24
30. Bennasser Y., Le S.Y., Benkirane M., and Jeang K.T. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22 5 (2005) 607-619
31. Bieniasz P.D. Intrinsic immunity: A front-line defense against viral attack. Nat. Immunol. 5 11 (2004) 1109-1115
32. Bieniasz P.D. Late budding domains and host proteins in enveloped virus release. Virology 344 1 (2006) 55-63
33. Bishop K.N., Holmes R.K., Sheehy A.M., Davidson N.O., Cho S.J., and Malim M.H. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14 15 (2004) 1392-1396
34. Bishop K.N., Holmes R.K., Sheehy A.M., and Malim M.H. APOBEC-mediated editing of viral RNA. Science 305 5684 (2004) 645
35. Blom D., Hirsch C., Stern P., Tortorella D., and Ploegh H.L. A glycosylated type I membrane protein becomes cytosolic when peptide: N-glycanase is compromised. EMBO J. 23 3 (2004) 650-658
36. Boname J.M., and Stevenson P.G. MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 15 4 (2001) 627-636
37. Bonifacino J.S., and Traub L.M. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Biochem. 72 (2003) 395-447
38. Boss J.M., and Jensen P.E. Transcriptional regulation of the MHC class II antigen presentation pathway. Curr. Opin. Immunol. 15 1 (2003) 105-111
39. Bowie A.G., Zhan J., and Marshall W.L. Viral appropriation of apoptotic and NF-kappaB signaling pathways. J. Cell. Biochem. 91 6 (2004) 1099-1108
40. Braun S., Matuschewski K., Rape M., Thoms S., and Jentsch S. Role of the ubiquitin-selective CDC48(UFD1/NPL4)chaperone (segregase) in ERAD of OLE1 and other substrates. EMBO J. 21 4 (2002) 615-621
41. Brodsky F.M., Lem L., Solache A., and Bennett E.M. Human pathogen subversion of antigen presentation. Immunol. Rev. 168 (1999) 199-215
42. Browne E.P., Li J., Chong M., and Littman D.R. Virus-host interactions: New insights from the small RNA world. Genome Biol. 6 11 (2005) 238
43. Bryant P., and Ploegh H. Class II MHC peptide loading by the professionals. Curr. Opin. Immunol. 16 1 (2004) 96-102
44. Buschhorn B.A., Kostova Z., Medicherla B., and Wolf D.H. A genome-wide screen identifies Yos9p as essential for ER-associated degradation of glycoproteins. FEBS Lett. 577 3 (2004) 422-426
45. Casso D.J., Tanda S., Biehs B., Martoglio B., and Kornberg T.B. Drosophila Signal peptide peptidase is an essential protease for larval development. Genetics 170 1 (2005) 139-148
46. Castelli C., Rivoltini L., Andreola G., Carrabba M., Renkvist N., and Parmiani G. T-cell recognition of melanoma-associated antigens. J. Cell. Physiol. 182 3 (2000) 323-331
47. Chapman H.A. Endosomal proteases in antigen presentation. Curr. Opin. Immunol. 18 1 (2006) 78-84
48. Chevalier M.S., Daniels G.M., and Johnson D.C. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation. J. Virol. 76 16 (2002) 8265-8275
49. Chou A.H., Tsai H.F., Wu Y.Y., Hu C.Y., Hwang L.H., Hsu P.I., and Hsu P.N. Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. J. Immunol. 174 4 (2005) 2160-2166
50. Clague M.J., and Urbe S. Hrs function: Viruses provide the clue. Trends Cell Biol. 13 12 (2003) 603-606
51. Collier-Hyams L.S., Sloane V., Batten B.C., and Neish A.S. Cutting edge: Bacterial modulation of epithelial signaling via changes in neddylation of cullin-1. J. Immunol. 175 7 (2005) 4194-4198
52. Collin N., Guerin J.L., Drexler I., Blanie S., Gelfi J., Boullier S., Foucras G., Sutter G., and Messud-Petit F. The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules. Virology 343 2 (2005) 171-178
53. Connell P., Ballinger C.A., Jiang J., Wu Y., Thompson L.J., Hohfeld J., and Patterson C. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat. Cell Biol. 3 1 (2001) 93-96
54. Coscoy L., and Ganem D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. USA 97 14 (2000) 8051-8056
55. Coscoy L., and Ganem D. PHD domains and E3 ubiquitin ligases: Viruses make the connection. Trends Cell Biol. 13 1 (2003) 7-12
56. Coscoy L., Sanchez D.J., and Ganem D. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J. Cell Biol. 155 7 (2001) 1265-1273
57. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., and Hsu M.L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7 2 (1997) 273-282
58. Crawshaw S.G., Martoglio B., Meacock S.L., and High S. A misassembled transmembrane domain of a polytopic protein associates with signal peptide peptidase. Biochem. J. 384 Pt. 1 (2004) 9-17
59. Cresswell P. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12 (1994) 259-293
60. Cresswell P., Ackerman A.L., Giodini A., Peaper D.R., and Wearsch P.A. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol. Rev. 207 (2005) 145-157
61. Crise B., and Rose J.K. Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum. J. Virol. 66 4 (1992) 2296-2301
62. Crotty S., and Ahmed R. Immunological memory in humans. Semin. Immunol. 16 3 (2004) 197-203
63. D'Andrea A., and Pellman D. Deubiquitinating enzymes: A new class of biological regulators. Crit. Rev. Biochem. Mol. Biol. 33 5 (1998) 337-352
64. d'Azzo A., Bongiovanni A., and Nastasi T. E3 ubiquitin ligases as regulators of membrane protein trafficking and degradation. Traffic 6 6 (2005) 429-441
65. Dao C.T., and Zhang D.E. ISG15: A ubiquitin-like enigma. Front Biosci. 10 (2005) 2701-2722
66. Dastur A., Beaudenon S., Kelley M., Krug R.M., and Huibregtse J.M. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J. Biol. Chem. 281 7 (2006) 4334-4338
67. Decottignies A., Evain A., and Ghislain M. Binding of Cdc48p to a ubiquitin-related UBX domain from novel yeast proteins involved in intracellular proteolysis and sporulation. Yeast 21 2 (2004) 127-139
68. Ding S.W., Li H., Lu R., Li F., and Li W.X. RNA silencing: A conserved antiviral immunity of plants and animals. Virus Res. 102 1 (2004) 109-115
69. Dreveny I., Pye V.E., Beuron F., Briggs L.C., Isaacson R.L., Matthews S.J., McKeown C., Yuan X., Zhang X., and Freemont P.S. p97 and close encounters of every kind: A brief review. Biochem. Soc. Trans. 32 Pt. 5 (2004) 715-720
70. Duncan L.M., Piper S., Dodd R.B., Saville M.K., Sanderson C.M., Luzio J.P., and Lehner P.J. Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J. 25 8 (2006) 1635-1645
71. Dunn C., Chalupny N.J., Sutherland C.L., Dosch S., Sivakumar P.V., Johnson D.C., and Cosman D. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med. 197 11 (2003) 1427-1439
72. Ellgaard L., and Helenius A. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4 3 (2003) 181-191
73. Elsasser S., Chandler-Militello D., Muller B., Hanna J., and Finley D. Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome. J. Biol. Chem. 279 26 (2004) 26817-26822
74. Eriksson K.K., Vago R., Calanca V., Galli C., Paganetti P., and Molinari M. EDEM contributes to maintenance of protein folding efficiency and secretory capacity. J. Biol. Chem. 279 43 (2004) 44600-44605
75. Esselens C., Oorschot V., Baert V., Raemaekers T., Spittaels K., Serneels L., Zheng H., Saftig P., De Strooper B., Klumperman J., and Annaert W. Presenilin 1 mediates the turnover of telencephalin in hippocampal neurons via an autophagic degradative pathway. J. Cell Biol. 166 7 (2004) 1041-1054
76. Falk C.S., Mach M., Schendel D.J., Weiss E.H., Hilgert I., and Hahn G. NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation. J. Immunol. 169 6 (2002) 3257-3266
77. Fang S., Ferrone M., Yang C., Jensen J.P., Tiwari S., and Weissman A.M. The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 98 25 (2001) 14422-14427
78. Farrell H., Degli-Esposti M., Densley E., Cretney E., Smyth M., and Davis-Poynter N. Cytomegalovirus MHC class I homologues and natural killer cells: An overview. Microbes Infect. 2 5 (2000) 521-532
79. Farrell P.J., Broeze R.J., and Lengyel P. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature 279 5713 (1979) 523-525
80. Faure J., Stalder R., Borel C., Sobo K., Piguet V., Demaurex N., Gruenberg J., and Trono D. ARF1 regulates Nef-induced CD4 degradation. Curr. Biol. 14 12 (2004) 1056-1064
81. Finlay B.B., and McFadden G. Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens. Cell 124 4 (2006) 767-782
82. Finley D., Ciechanover A., and Varshavsky A. Ubiquitin as a central cellular regulator. Cell 116 Suppl. 2 (2004) S29-S32 [2p following S32]
83. Flierman D., Ye Y., Dai M., Chau V., and Rapoport T.A. Polyubiquitin serves as a recognition signal, rather than a ratcheting molecule, during retrotranslocation of proteins across the endoplasmic reticulum membrane. J. Biol. Chem. 278 37 (2003) 34774-34782
84. Fortini M.E. Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling. Nat. Rev. Mol. Cell Biol. 3 9 (2002) 673-684
85. Friedmann E., Lemberg M.K., Weihofen A., Dev K.K., Dengler U., Rovelli G., and Martoglio B. Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins. J. Biol. Chem. 279 49 (2004) 50790-50798
86. Furman M.H., Dey N., Tortorella D., and Ploegh H.L. The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. J. Virol. 76 (2002) 11753-11756
87. Furman M.H., Ploegh H.L., and Tortorella D. Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules. J. Biol. Chem. 277 5 (2002) 3258-3267
88. Furman M.H., Loureiro J., Ploegh H.L., and Tortorella D. Ubiquitinylation of the cytosolic domain of a type I membrane protein is not required to initiate its dislocation from the endoplasmic reticulum. J. Biol. Chem. 278 37 (2003) 34804-34811
89. Galan J.E., and Collmer A. Type III secretion machines: Bacterial devices for protein delivery into host cells. Science 284 5418 (1999) 1322-1328
90. Galinier R., Gout E., Lortat-Jacob H., Wood J., and Chroboczek J. Adenovirus protein involved in virus internalization recruits ubiquitin-protein ligases. Biochemistry 41 48 (2002) 14299-14305
91. Garcin D., Marq J.B., Strahle L., le Mercier P., and Kolakofsky D. All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 295 2 (2002) 256-265
92. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L., Myszka D.G., and Sundquist W.I. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107 1 (2001) 55-65
93. Gauss R., Sommer T., and Jarosch E. The Hrd1p ligase complex forms a linchpin between ER-lumenal substrate selection and Cdc48p recruitment. EMBO J. 25 9 (2006) 1827-1835
94. Gavioli R., Gallerani E., Fortini C., Fabris M., Bottoni A., Canella A., Bonaccorsi A., Marastoni M., Micheletti F., Cafaro A., Rimessi P., Caputo A., et al. HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. J. Immunol. 173 6 (2004) 3838-3843
95. Gewurz B.E., Wang E.W., Tortorella D., Schust D.J., and Ploegh H.L. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner. J. Virol. 75 11 (2001) 5197-5204
96. Gewurz B.E., Ploegh H.L., and Tortorella D. US2, a human cytomegalovirus-encoded type I membrane protein, contains a non-cleavable amino-terminal signal peptide. J. Biol. Chem. 277 13 (2002) 11306-11313
97. Geyer M., Yu H., Mandic R., Linnemann T., Zheng Y.H., Fackler O.T., and Peterlin B.M. Subunit H of the V-ATPase binds to the medium chain of adaptor protein complex 2 and connects Nef to the endocytic machinery. J. Biol. Chem. 277 32 (2002) 28521-28529
98. Ghislain M., Dohmen R.J., Levy F., and Varshavsky A. Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces cerevisiae. EMBO J. 15 18 (1996) 4884-4899
99. Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J., Jacobs B.S., Borden E.C., Li J., Virgin H.W., and Zhang D.E. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem. Biophys. Res. Commun. 336 2 (2005) 496-506
100. Gilbert M.J., Riddell S.R., Plachter B., and Greenberg P.D. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 383 6602 (1996) 720-722
101. Goto E., Ishido S., Sato Y., Ohgimoto S., Ohgimoto K., Nagano-Fujii M., and Hotta H. c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity. J. Biol. Chem. 278 17 (2003) 14657-14668
102. Grigorenko A.P., Moliaka Y.K., Soto M.C., Mello C.C., and Rogaev E.I. The Caenorhabditis elegans IMPAS gene, imp-2, is essential for development and is functionally distinct from related presenilins. Proc. Natl. Acad. Sci. USA 101 41 (2004) 14955-14960
103. Groll M., Ditzel L., Lowe J., Stock D., Bochtler M., Bartunik H.D., and Huber R. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386 6624 (1997) 463-471
104. Groll M., Bajorek M., Kohler A., Moroder L., Rubin D.M., Huber R., Glickman M.H., and Finley D. A gated channel into the proteasome core particle. Nat. Struct. Biol. 7 11 (2000) 1062-1067
105. Groothuis T.A., and Neefjes J. The many roads to cross-presentation. J. Exp. Med. 202 10 (2005) 1313-1318
106. Gruhler A., Peterson P.A., and Fruh K. Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association. Traffic 1 4 (2000) 318-325
107. Guerin J.L., Gelfi J., Boullier S., Delverdier M., Bellanger F.A., Bertagnoli S., Drexler I., Sutter G., and Messud-Petit F. Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins. J. Virol. 76 6 (2002) 2912-2923
108. Guermonprez P., and Amigorena S. Pathways for antigen cross presentation. Springer Semin. Immunopathol. 26 3 (2005) 257-271
109. Gurlebeck D., Thieme F., and Bonas U. Type III effector proteins from the plant pathogen Xanthomonas and their role in the interaction with the host plant. J. Plant Physiol. 163 3 (2006) 233-255
110. Haglund K., and Dikic I. Ubiquitylation and cell signaling. EMBO J. 24 19 (2005) 3353-3359
111. Halaban R., Svedine S., Cheng E., Smicun Y., Aron R., and Hebert D.N. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism. Proc. Natl. Acad. Sci. USA 97 11 (2000) 5889-5894
112. Halenius A., Momburg F., Reinhard H., Bauer D., Lobigs M., and Hengel H. Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. J. Biol. Chem. 281 9 (2006) 5383-5390
113. Hammond C., Braakman I., and Helenius A. Role of N-linked oligosaccharide recognition, glucose trimming, and calnexin in glycoprotein folding and quality control. Proc. Natl. Acad. Sci. USA 91 3 (1994) 913-917
114. Hampton R.Y. ER-associated degradation in protein quality control and cellular regulation. Curr. Opin. Cell Biol. 14 4 (2002) 476-482
115. Hampton R.Y., and Bhakta H. Ubiquitin-mediated regulation of 3-hydroxy-3-methylglutaryl-CoA reductase. Proc. Natl. Acad. Sci. USA 94 24 (1997) 12944-12948
116. Hampton R.Y., Gardner R.G., and Rine J. Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. Mol. Biol. Cell 7 12 (1996) 2029-2044
117. Hardt W.D., and Galan J.E. A secreted Salmonella protein with homology to an avirulence determinant of plant pathogenic bacteria. Proc. Natl. Acad. Sci. USA 94 18 (1997) 9887-9892
118. Harris R.S., and Liddament M.T. Retroviral restriction by APOBEC proteins. Nat. Rev. Immunol. 4 11 (2004) 868-877
119. Hartmann-Petersen R., and Gordon C. Integral UBL domain proteins: A family of proteasome interacting proteins. Semin. Cell Dev. Biol. 15 2 (2004) 247-259
120. Hartmann-Petersen R., and Gordon C. Protein degradation: Recognition of ubiquitinylated substrates. Curr. Biol. 14 18 (2004) R754-R756
121. Hartmann-Petersen R., Seeger M., and Gordon C. Transferring substrates to the 26S proteasome. Trends Biochem. Sci. 28 1 (2003) 26-31
122. Harty R.N., Brown M.E., McGettigan J.P., Wang G., Jayakar H.R., Huibregtse J.M., Whitt M.A., and Schnell M.J. Rhabdoviruses and the cellular ubiquitin-proteasome system: A budding interaction. J. Virol. 75 22 (2001) 10623-10629
123. Hassink G., Kikkert M., van Voorden S., Lee S.J., Spaapen R., van Laar T., Coleman C.S., Bartee E., Fruh K., Chau V., and Wiertz E. TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the endoplasmic reticulum. Biochem. J. 388 Pt. 2 (2005) 647-655
124. Hatakeyama S., Yada M., Matsumoto M., Ishida N., and Nakayama K.I. U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem. 276 35 (2001) 33111-33120
125. Heemels M.T., and Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64 (1995) 463-491
126. Hegde N.R., and Johnson D.C. Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells. J. Virol. 77 17 (2003) 9287-9294
127. Hegde N.R., Tomazin R.A., Wisner T.W., Dunn C., Boname J.M., Lewinsohn D.M., and Johnson D.C. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: A novel mechanism for evading major histocompatibility complex class II antigen presentation. J. Virol. 76 21 (2002) 10929-10941
128. Heinemeyer W., Ramos P.C., and Dohmen R.J. The ultimate nanoscale mincer: Assembly, structure and active sites of the 20S proteasome core. Cell. Mol. Life Sci. 61 13 (2004) 1562-1578
129. Helenius A., and Aebi M. Roles of N-linked glycans in the endoplasmic reticulum. Annu. Rev. Biochem. 73 (2004) 1019-1049
130. Hendil K.B., and Hartmann-Petersen R. Proteasomes: A complex story. Curr. Protein Pept. Sci. 5 3 (2004) 135-151
131. Hengel H., and Koszinowski U.H. Interference with antigen processing by viruses. Curr. Opin. Immunol. 9 4 (1997) 470-476
132. Hengel H., Koopmann J.O., Flohr T., Muranyi W., Goulmy E., Hammerling G.J., Koszinowski U.H., and Momburg F. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6 5 (1997) 623-632
133. Hengel H., Brune W., and Koszinowski U.H. Immune evasion by cytomegalovirus-survival strategies of a highly adapted opportunist. Trends Microbiol. 6 5 (1998) 190-197
134. Hengel H., Reusch U., Gutermann A., Ziegler H., Jonjic S., Lucin P., and Koszinowski U.H. Cytomegaloviral control of MHC class I function in the mouse. Immunol. Rev. 168 (1999) 167-176
135. Hengel H., Koszinowski U.H., and Conzelmann K.K. Viruses know it all: New insights into IFN networks. Trends Immunol. 26 7 (2005) 396-401
136. Hershko A., and Ciechanover A. The ubiquitin system for protein degradation. Annu. Rev. Biochem. 61 (1992) 761-807
137. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
138. Hewitt E.W., Gupta S.S., and Lehner P.J. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J. 20 3 (2001) 387-396
139. Hicke L. A new ticket for entry into budding vesicles-ubiquitin. Cell 106 5 (2001) 527-530
140. Hicke L., and Dunn R. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol. 19 (2003) 141-172
141. Hierro A., Sun J., Rusnak A.S., Kim J., Prag G., Emr S.D., and Hurley J.H. Structure of the ESCRT-II endosomal trafficking complex. Nature 431 7005 (2004) 221-225
142. Hilleman M.R. Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc. Natl. Acad. Sci. USA 101 Suppl. 2 (2004) 14560-14566
143. Hirsch C., and Ploegh H.L. Intracellular targeting of the proteasome. Trends Cell Biol. 10 7 (2000) 268-272
144. Hirsch C., Blom D., and Ploegh H.L. A role for N-glycanase in the cytosolic turnover of glycoproteins. EMBO J. 22 5 (2003) 1036-1046
145. Hirsch C., Jarosch E., Sommer T., and Wolf D.H. Endoplasmic reticulum-associated protein degradation-one model fits all?. Biochim. Biophys. Acta 1695 1-3 (2004) 215-223
146. Hiscott J., Kwon H., and Genin P. Hostile takeovers: Viral appropriation of the NF-kappaB pathway. J. Clin. Invest. 107 2 (2001) 143-151
147. Hmama Z., Gabathuler R., Jefferies W.A., de Jong G., and Reiner N.E. Attenuation of HLA-DR expression by mononuclear phagocytes infected with Mycobacterium tuberculosis is related to intracellular sequestration of immature class II heterodimers. J. Immunol. 161 9 (1998) 4882-4893
148. Hochstrasser M. SP-RING for SUMO: New functions bloom for a ubiquitin-like protein. Cell 107 1 (2001) 5-8
149. Hodge D.R., Hurt E.M., and Farrar W.L. The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41 16 (2005) 2502-2512
150. Honey K., and Rudensky A.Y. Lysosomal cysteine proteases regulate antigen presentation. Nat. Rev. Immunol. 3 6 (2003) 472-482
151. Hoppe T. Multiubiquitylation by E4 enzymes: 'One size' doesn't fit all. Trends Biochem. Sci. 30 4 (2005) 183-187
152. Hori O., Ichinoda F., Yamaguchi A., Tamatani T., Taniguchi M., Koyama Y., Katayama T., Tohyama M., Stern D.M., Ozawa K., Kitao Y., and Ogawa S. Role of Herp in the endoplasmic reticulum stress response. Genes Cells 9 5 (2004) 457-469
153. Hsing L.C., and Rudensky A.Y. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207 (2005) 229-241
154. Hu M., Li P., Li M., Li W., Yao T., Wu J.W., Gu W., Cohen R.E., and Shi Y. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111 7 (2002) 1041-1054
155. Huppa J.B., and Ploegh H.L. The alpha chain of the T cell antigen receptor is degraded in the cytosol. Immunity 7 1 (1997) 113-122
156. Hurley J.H., and Emr S.D. The ESCRT complexes: Structure and mechanism of a membrane-trafficking network. Annu. Rev. Biophys. Biomol. Struct. 35 (2006) 277-298
157. Hussain S., Zwilling B.S., and Lafuse W.P. Mycobacterium avium infection of mouse macrophages inhibits IFN-gamma Janus kinase-STAT signaling and gene induction by down-regulation of the IFN-gamma receptor. J. Immunol. 163 4 (1999) 2041-2048
158. Imai Y., Soda M., and Takahashi R. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 275 46 (2000) 35661-35664
159. Imai Y., Soda M., Hatakeyama S., Akagi T., Hashikawa T., Nakayama K.I., and Takahashi R. CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol. Cells 10 1 (2002) 55-67
160. Ingham R.J., Gish G., and Pawson T. The Nedd4 family of E3 ubiquitin ligases: Functional diversity within a common modular architecture. Oncogene 23 11 (2004) 1972-1984
161. Ingham R.J., Raaijmakers J., Lim C.S., Mbamalu G., Gish G., Chen F., Matskova L., Ernberg I., Winberg G., and Pawson T. The Epstein-Barr virus protein, latent membrane protein 2A, co-opts tyrosine kinases used by the T cell receptor. J. Biol. Chem. 280 40 (2005) 34133-34142
162. Inohara C., McDonald C., and Nunez G. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74 (2005) 355-383
163. Ishido S., Wang C., Lee B.S., Cohen G.B., and Jung J.U. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74 11 (2000) 5300-5309
164. Jakob C.A., Bodmer D., Spirig U., Battig P., Marcil A., Dignard D., Bergeron J.J., Thomas D.Y., and Aebi M. Htm1p, a mannosidase-like protein, is involved in glycoprotein degradation in yeast. EMBO Rep. 2 5 (2001) 423-430
165. Janjusevic R., Abramovitch R.B., Martin G.B., and Stebbins C.E. A bacterial inhibitor of host programmed cell death defenses is an E3 ubiquitin ligase. Science 311 5758 (2006) 222-226
166. Janvier K., Craig H., Hitchin D., Madrid R., Sol-Foulon N., Renault L., Cherfils J., Cassel D., Benichou S., and Guatelli J. HIV-1 Nef stabilizes the association of adaptor protein complexes with membranes. J. Biol. Chem. 278 10 (2003) 8725-8732
167. Janvier K., Kato Y., Boehm M., Rose J.R., Martina J.A., Kim B.Y., Venkatesan S., and Bonifacino J.S. Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 gamma-sigma1 and AP-3 delta-sigma3 hemicomplexes. J. Cell Biol. 163 6 (2003) 1281-1290
168. Jarosch E., Taxis C., Volkwein C., Bordallo J., Finley D., Wolf D.H., and Sommer T. Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat. Cell Biol. 4 2 (2002) 134-139
169. Jensen T.J., Loo M.A., Pind S., Williams D.B., Goldberg A.L., and Riordan J.R. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83 1 (1995) 129-135
170. Jin J., and Harper J.W. RING finger specificity in SCF-driven protein destruction. Dev. Cell 2 6 (2002) 685-687
171. Jin J., Cardozo T., Lovering R.C., Elledge S.J., Pagano M., and Harper J.W. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 18 21 (2004) 2573-2580
172. Jin Y.J., Zhang X., Boursiquot J.G., and Burakoff S.J. CD4 phosphorylation partially reverses Nef down-regulation of CD4. J. Immunol. 173 9 (2004) 5495-5500
173. Jin Y.J., Cai C.Y., Zhang X., Zhang H.T., Hirst J.A., and Burakoff S.J. HIV Nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent. J. Immunol. 175 5 (2005) 3157-3164
174. Joazeiro C.A., and Weissman A.M. RING finger proteins: Mediators of ubiquitin ligase activity. Cell 102 5 (2000) 549-552
175. Johnson E.S., Ma P.C., Ota I.M., and Varshavsky A. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 270 29 (1995) 17442-17456
176. Jones T.R., Hanson L.K., Sun L., Slater J.S., Stenberg R.M., and Campbell A.E. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69 8 (1995) 4830-4831
177. Jones T.R., Wiertz E.J., Sun L., Fish K.N., Nelson J.A., and Ploegh H.L. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. USA 93 21 (1996) 11327-11333
178. Joseph A.M., Kumar M., and Mitra D. Nef: "Necessary and enforcing factor" in HIV infection. Curr. HIV Res. 3 1 (2005) 87-94
179. Jutras I., and Desjardins M. Phagocytosis: At the crossroads of innate and adaptive immunity. Annu. Rev. Cell Dev. Biol. 21 (2005) 511-527
180. Kalies K.U., Allan S., Sergeyenko T., Kroger H., and Romisch K. The protein translocation channel binds proteasomes to the endoplasmic reticulum membrane. EMBO J. 24 13 (2005) 2284-2293
181. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
182. Katiyar S., Li G., and Lennarz W.J. A complex between peptide: N-glycanase and two proteasome-linked proteins suggests a mechanism for the degradation of misfolded glycoproteins. Proc. Natl. Acad. Sci. USA 101 38 (2004) 13774-13779
183. Kattenhorn L.M., Korbel G.A., Kessler B.M., Spooner E., and Ploegh H.L. A deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviridae. Mol. Cells 19 4 (2005) 547-557
184. Katzmann D.J., Odorizzi G., and Emr S.D. Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 3 12 (2002) 893-905
185. Kawakami T., Chiba T., Suzuki T., Iwai K., Yamanaka K., Minato N., Suzuki H., Shimbara N., Hidaka Y., Osaka F., Omata M., and Tanaka K. NEDD8 recruits E2-ubiquitin to SCF E3 ligase. EMBO J. 20 15 (2001) 4003-4012
186. Keppler O.T., Tibroni N., Venzke S., Rauch S., and Fackler O.T. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1. J. Leukoc. Biol. 79 3 (2006) 616-627
187. Kerkau T., Bacik I., Bennink J.R., Yewdell J.W., Hunig T., Schimpl A., and Schubert U. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J. Exp. Med. 185 7 (1997) 1295-1305
188. Kikkert M., Doolman R., Dai M., Avner R., Hassink G., van Voorden S., Thanedar S., Roitelman J., Chau V., and Wiertz E. Human HRD1 is an E3 ubiquitin ligase involved in degradation of proteins from the endoplasmic reticulum. J. Biol. Chem. 279 5 (2004) 3525-3534
189. Kim D.W., Lenzen G., Page A.L., Legrain P., Sansonetti P.J., and Parsot C. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl. Acad. Sci. USA 102 39 (2005) 14046-14051
190. Kim K.I., Ahn J., Liu C., Tanabe K., Apodaca J., Suzuki T., and Rao H. The Png1-Rad23 complex regulates glycoprotein turnover. J. Cell Biol. 172 2 (2006) 211-219
191. Kim K.I., Yan M., Malakhova O., Luo J.K., Shen M.F., Zou W., de la Torre J.C., and Zhang D.E. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol. Cell. Biol. 26 (2006) 472-479
192. Kim Y.M., Pan J.Y., Korbel G.A., Peperzak V., Boes M., and Ploegh H.L. Monovalent ligation of the B cell receptor induces receptor activation but fails to promote antigen presentation. Proc. Natl. Acad. Sci. USA 103 9 (2006) 3327-3332
193. Kimura T., Nishikawa M., and Ohyama A. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: Vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum. J. Biochem. (Tokyo) 115 5 (1994) 1010-1020
194. Klenerman P., and Hill A. T cells and viral persistence: Lessons from diverse infections. Nat. Immunol. 6 9 (2005) 873-879
195. Klinger P.P., and Schubert U. The ubiquitin-proteasome system in HIV replication: Potential targets for antiretroviral therapy. Expert Rev. Anti Infect. Ther. 3 1 (2005) 61-79
196. Kloetzel P.M. The proteasome and MHC class I antigen processing. Biochim. Biophys. Acta 1695 1-3 (2004) 225-233
197. Kloetzel P.M., and Ossendorp F. Proteasome and peptidase function in MHC-class-I-mediated antigen presentation. Curr. Opin. Immunol. 16 1 (2004) 76-81
198. Knobeloch K.P., Utermohlen O., Kisser A., Prinz M., and Horak I. Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice. Mol. Cell Biol. 25 24 (2005) 11030-11034
199. Knop M., Finger A., Braun T., Hellmuth K., and Wolf D.H. Der1, a novel protein specifically required for endoplasmic reticulum degradation in yeast. EMBO J. 15 4 (1996) 753-763
200. Kohler A., Bajorek M., Groll M., Moroder L., Rubin D.M., Huber R., Glickman M.H., and Finley D. The substrate translocation channel of the proteasome. Biochimie 83 3-4 (2001) 325-332
201. Kokame K., Agarwala K.L., Kato H., and Miyata T. Herp, a new ubiquitin-like membrane protein induced by endoplasmic reticulum stress. J. Biol. Chem. 275 42 (2000) 32846-32853
202. Kopan R., and Ilagan M.X. Gamma-secretase: Proteasome of the membrane?. Nat. Rev. Mol. Cell. Biol. 5 6 (2004) 499-504
203. Korenaga M., Wang T., Li Y., Showalter L.A., Chan T., Sun J., and Weinman S.A. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J. Biol. Chem. 280 45 (2005) 37481-37488
204. Kornilova A.Y., Das C., and Wolfe M.S. Differential effects of inhibitors on the gamma-secretase complex. Mechanistic implications. J. Biol. Chem. 278 19 (2003) 16470-16473
205. Kostelansky M.S., Sun J., Lee S., Kim J., Ghirlando R., Hierro A., Emr S.D., and Hurley J.H. Structural and functional organization of the ESCRT-I trafficking complex. Cell 125 1 (2006) 113-126
206. Kostova Z., and Wolf D.H. For whom the bell tolls: Protein quality control of the endoplasmic reticulum and the ubiquitin-proteasome connection. EMBO J. 22 10 (2003) 2309-2317
207. Krawitz P., Haffner C., Fluhrer R., Steiner H., Schmid B., and Haass C. Differential localization and identification of a critical aspartate suggest non-redundant proteolytic functions of the presenilin in homologues SPPL2b and SPPL3. J. Biol. Chem. 280 47 (2005) 39515-39523
208. Kreft S.G., Wang L., and Hochstrasser M. Membrane topology of the yeast endoplasmic reticulum-localized ubiquitin ligase Doa10 and comparison with its human ortholog TEB4 (MARCH-VI). J. Biol. Chem. 281 8 (2006) 4646-4653
209. Kruger E., Kuckelkorn U., Sijts A., and Kloetzel P.M. The components of the proteasome system and their role in MHC class I antigen processing. Rev. Physiol. Biochem. Pharmacol. 148 (2003) 81-104
210. Kubori T., and Galan J.E. Temporal regulation of salmonella virulence effector function by proteasome-dependent protein degradation. Cell 115 3 (2003) 333-342
211. Kumar V., and McNerney M.E. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat. Rev. Immunol. 5 5 (2005) 363-374
212. Kunzi M.S., and Pitha P.M. Role of interferon-stimulated gene ISG-15 in the interferon-omega-mediated inhibition of human immunodeficiency virus replication. J. Interferon Cytokine Res. 16 11 (1996) 919-927
213. Kyritsis C., Gorbulev S., Hutschenreiter S., Pawlitschko K., Abele R., and Tampe R. Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. J. Biol. Chem. 276 51 (2001) 48031-48039
214. Lama J., and Ware C.F. Human immunodeficiency virus type 1 Nef mediates sustained membrane expression of tumor necrosis factor and the related cytokine LIGHT on activated T cells. J. Virol. 74 20 (2000) 9396-9402
215. Lama J., Mangasarian A., and Trono D. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner. Curr. Biol. 9 12 (1999) 622-631
216. Lamsoul I., Lodewick J., Lebrun S., Brasseur R., Burny A., Gaynor R.B., and Bex F. Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein. Mol. Cell. Biol. 25 23 (2005) 10391-10406
217. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 23 (2005) 225-274
218. Le Gall S., Erdtmann L., Benichou S., Berlioz-Torrent C., Liu L., Benarous R., Heard J.M., and Schwartz O. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 8 4 (1998) 483-495
219. Lee S., Park B., and Ahn K. Determinant for endoplasmic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein. J. Virol. 77 3 (2003) 2147-2156
220. Lehner P.J., Karttunen J.T., Wilkinson G.W., and Cresswell P. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc. Natl. Acad. Sci. USA 94 13 (1997) 6904-6909
221. Lehner P.J., Hoer S., Dodd R., and Duncan L.M. Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol. Rev. 207 (2005) 112-125
222. Lemberg M.K., and Martoglio B. Requirements for signal peptide peptidase-catalyzed intramembrane proteolysis. Mol. Cells 10 4 (2002) 735-744
223. Lemberg M.K., and Martoglio B. On the mechanism of SPP-catalysed intramembrane proteolysis; conformational control of peptide bond hydrolysis in the plane of the membrane. FEBS Lett. 564 3 (2004) 213-218
224. Lemberg M.K., Bland F.A., Weihofen A., Braud V.M., and Martoglio B. Intramembrane proteolysis of signal peptides: An essential step in the generation of HLA-E epitopes. J. Immunol. 167 11 (2001) 6441-6446
225. Lemberg M.K., Menendez J., Misik A., Garcia M., Koth C.M., and Freeman M. Mechanism of intramembrane proteolysis investigated with purified rhomboid proteases. EMBO J. 24 3 (2005) 464-472
226. Leong C.C., Chapman T.L., Bjorkman P.J., Formankova D., Mocarski E.S., Phillips J.H., and Lanier L.L. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: The role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 187 10 (1998) 1681-1687
227. Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P.M., Klein G., Kurilla M.G., and Masucci M.G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375 6533 (1995) 685-688
228. Li F., and Wild C. HIV-1 assembly and budding as targets for drug discovery. Curr. Opin. Invest. Drugs 6 2 (2005) 148-154
229. Li G., Zhou X., Zhao G., Schindelin H., and Lennarz W.J. Multiple modes of interaction of the deglycosylation enzyme, mouse peptide N-glycanase, with the proteasome. Proc. Natl. Acad. Sci. USA 102 44 (2005) 15809-15814
230. Li G., Zhao G., Zhou X., Schindelin H., and Lennarz W.J. The AAA ATPase p97 links peptide N-glycanase to the endoplasmic reticulum-associated E3 ligase autocrine motility factor receptor. Proc. Natl. Acad. Sci. USA 103 22 (2006) 8348-8353
231. Li Q., Spriggs M.K., Kovats S., Turk S.M., Comeau M.R., Nepom B., and Hutt-Fletcher L.M. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes. J. Virol. 71 6 (1997) 4657-4662
232. Li S.J., and Hochstrasser M. The Ulp1 SUMO isopeptidase: Distinct domains required for viability, nuclear envelope localization, and substrate specificity. J. Cell Biol. 160 7 (2003) 1069-1081
233. Li T., Chen X., Garbutt K.C., Zhou P., and Zheng N. Structure of DDB1 in complex with a paramyxovirus V protein: Viral hijack of a propeller cluster in ubiquitin ligase. Cell 124 1 (2006) 105-117
234. Liang J.S., Kim T., Fang S., Yamaguchi J., Weissman A.M., Fisher E.A., and Ginsberg H.N. Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells. J. Biol. Chem. 278 26 (2003) 23984-23988
235. Licata J.M., Simpson-Holley M., Wright N.T., Han Z., Paragas J., and Harty R.N. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: Involvement of host proteins TSG101 and VPS-4. J. Virol. 77 3 (2003) 1812-1819
236. Lilley B.N., and Ploegh H.L. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429 6994 (2004) 834-840
237. Lilley B.N., and Ploegh H.L. Multiprotein complexes that link dislocation, ubiquitination, and extraction of misfolded proteins from the endoplasmic reticulum membrane. Proc. Natl. Acad. Sci. USA 102 40 (2005) 14296-14301
238. Lilley B.N., and Ploegh H.L. Viral modulation of antigen presentation: Manipulation of cellular targets in the ER and beyond. Immunol. Rev. 207 (2005) 126-144
239. Lilley B.N., Tortorella D., and Ploegh H.L. Dislocation of a type I membrane protein requires interactions between membrane-spanning segments within the lipid bilayer. Mol. Biol. Cell 14 9 (2003) 3690-3698
240. Lin W., Choe W.H., Hiasa Y., Kamegaya Y., Blackard J.T., Schmidt E.V., and Chung R.T. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1. Gastroenterology 128 4 (2005) 1034-1041
241. Lindner H.A., Fotouhi-Ardakani N., Lytvyn V., Lachance P., Sulea T., and Menard R. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J. Virol. 79 24 (2005) 15199-15208
242. Liu Y.C. Ubiquitin ligases and the immune response. Annu. Rev. Immunol. 22 (2004) 81-127
243. Liu Y.C., Penninger J., and Karin M. Immunity by ubiquitylation: A reversible process of modification. Nat. Rev. Immunol. 5 12 (2005) 941-952
244. Lodoen M.B., and Lanier L.L. Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3 1 (2005) 59-69
245. Lord J.M., Ceriotti A., and Roberts L.M. ER dislocation: Cdc48p/p97 gets into the AAAct. Curr. Biol. 12 5 (2002) R182-R184
246. Loureiro J., Lilley B.N., Spooner E., Noriega V., Tortorella D., and Ploegh H.L. Signal peptide peptidase is required for dislocation from the endoplasmic reticulum. Nature 441 7095 (2006) 894-897
247. Luo K., Xiao Z., Ehrlich E., Yu Y., Liu B., Zheng S., and Yu X.F. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc. Natl. Acad. Sci. USA 102 32 (2005) 11444-11449
248. Lybarger L., Wang X., Harris M., and Hansen T.H. Viral immune evasion molecules attack the ER peptide-loading complex and exploit ER-associated degradation pathways. Curr. Opin. Immunol. 17 1 (2005) 71-78
249. Lybarger L., Wang X., Harris M.R., Virgin H.W. and Hansen T.H. Virus subversion of the MHC class I peptide-loading complex. Immunity 18 1 (2003) 121-130
250. Machold R.P., Wiertz E.J., Jones T.R., and Ploegh H.L. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J. Exp. Med. 185 2 (1997) 363-366
251. Malakhov M.P., Kim K.I., Malakhova O.A., Jacobs B.S., Borden E.C., and Zhang D.E. High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J. Biol. Chem. 278 19 (2003) 16608-16613
252. Malakhov M.P., Malakhova O.A., Kim K.I., Ritchie K.J., and Zhang D.E. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277 12 (2002) 9976-9981
253. Malakhova O.A., Kim K.I., Luo J.K., Zou W., Kumar K.G., Fuchs S.Y., Shuai K., and Zhang D.E. UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25 11 (2006) 2358-2367
254. Mandic R., Fackler O.T., Geyer M., Linnemann T., Zheng Y.H., and Peterlin B.M. Negative factor from SIV binds to the catalytic subunit of the V-ATPase to internalize CD4 and to increase viral infectivity. Mol. Biol. Cell 12 2 (2001) 463-473
255. Mangasarian A., and Trono D. The multifaceted role of HIV Nef. Res. Virol. 148 1 (1997) 30-33
256. Mangasarian A., Piguet V., Wang J.K., Chen Y.L., and Trono D. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73 3 (1999) 1964-1973
257. Mansouri M., Bartee E., Gouveia K., Hovey Nerenberg B.T., Barrett J., Thomas L., Thomas G., McFadden G., and Fruh K. The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4. J. Virol. 77 2 (2003) 1427-1440
258. Margottin F., Bour S.P., Durand H., Selig L., Benichou S., Richard V., Thomas D., Strebel K., and Benarous R. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cells 1 4 (1998) 565-574
259. Marsh M., and Helenius A. Virus entry: Open sesame. Cell 124 4 (2006) 729-740
260. Martin-Serrano J., Zang T., and Bieniasz P.D. Role of ESCRT-I in retroviral budding. J. Virol. 77 8 (2003) 4794-4804
261. Martoglio B. Intramembrane proteolysis and post-targeting functions of signal peptides. Biochem. Soc. Trans. 31 Pt 6 (2003) 1243-1247
262. Martoglio B., and Golde T.E. Intramembrane-cleaving aspartic proteases and disease: Presenilins, signal peptide peptidase and their homologs. Hum. Mol. Genet. 12 Spec. No. 2 (2003) R201-R206
263. Martoglio B., Graf R., and Dobberstein B. Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. EMBO J. 16 22 (1997) 6636-6645
264. Mason N.J., Artis D., and Hunter C.A. New lessons from old pathogens: What parasitic infections have taught us about the role of nuclear factor-kappaB in the regulation of immunity. Immunol. Rev. 201 (2004) 48-56
265. McLauchlan J., Lemberg M.K., Hope G., and Martoglio B. Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J. 21 15 (2002) 3980-3988
266. McMahon H.T., and Mills I.G. COP and clathrin-coated vesicle budding: Different pathways, common approaches. Curr. Opin. Cell Biol. 16 4 (2004) 379-391
267. Meacham G.C., Patterson C., Zhang W., Younger J.M., and Cyr D.M. The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat. Cell Biol. 3 1 (2001) 100-105
268. Medicherla B., Kostova Z., Schaefer A., and Wolf D.H. A genomic screen identifies Dsk2p and Rad23p as essential components of ER-associated degradation. EMBO Rep. 5 7 (2004) 692-697
269. Merlo A., Saverino D., Tenca C., Grossi C.E., Bruno S., and Ciccone E. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis. Infect. Immun. 69 10 (2001) 6022-6029
270. Meusser B., Hirsch C., Jarosch E., and Sommer T. ERAD: The long road to destruction. Nat. Cell Biol. 7 8 (2005) 766-772
271. Meyer K., Basu A., Saito K., Ray R.B., and Ray R. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death. Virology 336 2 (2005) 198-207
272. Migone T.S., Humbert M., Rascle A., Sanden D., D'Andrea A., and Johnston J.A. The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal. Blood 98 6 (2001) 1935-1941
273. Miller D.M., Rahill B.M., Boss J.M., Lairmore M.D., Durbin J.E., Waldman J.W., and Sedmak D.D. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187 5 (1998) 675-683
274. Mills K.H. Regulatory T cells: Friend or foe in immunity to infection?. Nat. Rev. Immunol. 4 11 (2004) 841-855
275. Misaghi S., Pacold M.E., Blom D., Ploegh H.L., and Korbel G.A. Structural and functional analysis of human cytomegalovirus US3 protein. J. Virol. 78 1 (2004) 413-423
276. Misaghi S., Sun Z.Y., Stern P., Gaudet R., Wagner G., and Ploegh H. Using a small molecule inhibitor of peptide: N-glycanase to probe its role in glycoprotein turnover. Chem. Biol. 11 12 (2004) 1677-1687
277. Misaghi S., Balsara Z.R., Catic A., Spooner E., Ploegh H.L., and Starnbach M.N. Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Mol. Microbiol. 61 1 (2006) 142-150
278. Mocarski Jr. E.S. Immune escape and exploitation strategies of cytomegaloviruses: Impact on and imitation of the major histocompatibility system. Cell. Microbiol. 6 8 (2004) 707-717
279. Molinari M., Calanca V., Galli C., Lucca P., and Paganetti P. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 299 5611 (2003) 1397-1400
280. Molinari M., Salio M., Galli C., Norais N., Rappuoli R., Lanzavecchia A., and Montecucco C. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J. Exp. Med. 187 1 (1998) 135-140
281. Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J., and Orth K. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312 5777 (2006) 1211-1214
282. Mullally J.E., Chernova T., and Wilkinson K.D. Doa1 is a Cdc48 adapter that possesses a novel ubiquitin binding domain. Mol. Cell. Biol. 26 3 (2006) 822-830
283. Munz C., Steinman R.M., and Fujii S. Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 202 2 (2005) 203-207
284. Murata S., Minami Y., Minami M., Chiba T., and Tanaka K. CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep. 2 12 (2001) 1133-1138
285. Murata S., Chiba T., and Tanaka K. CHIP: A quality-control E3 ligase collaborating with molecular chaperones. Int. J. Biochem. Cell Biol. 35 5 (2003) 572-578
286. Nabi I.R., Watanabe H., and Raz A. Autocrine motility factor and its receptor: Role in cell locomotion and metastasis. Cancer Metastasis Rev. 11 1 (1992) 5-20
287. Nelson R.F., Glenn K.A., Miller V.M., Wen H., and Paulson H.L. A novel route for F-box protein mediated ubiquitination links CHIP to glycoprotein quality control. J. Biol. Chem. 281 29 (2006) 20242-20251
288. Neuber O., Jarosch E., Volkwein C., Walter J., and Sommer T. Ubx2 links the Cdc48 complex to ER-associated protein degradation. Nat. Cell Biol. 7 10 (2005) 993-998
289. Neumann J., Eis-Hubinger A.M., and Koch N. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. J. Immunol. 171 6 (2003) 3075-3083
290. Nijman S.M., Luna-Vargas M.P., Velds A., Brummelkamp T.R., Dirac A.M., Sixma T.K., and Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 123 5 (2005) 773-786
291. Oda Y., Okada T., Yoshida H., Kaufman R.J., Nagata K., and Mori K. Derlin-2 and Derlin-3 are regulated by the mammalian unfolded protein response and are required for ER-associated degradation. J. Cell Biol. 172 3 (2006) 383-393
292. Okuda M., Li K., Beard M.R., Showalter L.A., Scholle F., Lemon S.M., and Weinman S.A. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 122 2 (2002) 366-375
293. Okumura A., Lu G., Pitha-Rowe I., and Pitha P.M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. USA 103 5 (2006) 1440-1445
294. Omura T., Yoshiyama M., Hayashi T., Nishiguchi S., Kaito M., Horiike S., Fukuda K., Inamoto S., Kitaura Y., Nakamura Y., Teragaki M., Tokuhisa T., et al. Core protein of hepatitis C virus induces cardiomyopathy. Circ. Res. 96 2 (2005) 148-150
295. O'Neil K.T., and DeGrado W.F. How calmodulin binds its targets: Sequence independent recognition of amphiphilic alpha-helices. Trends Biochem. Sci. 15 2 (1990) 59-64
296. Orange J.S., Fassett M.S., Koopman L.A., Boyson J.E., and Strominger J.L. Viral evasion of natural killer cells. Nat. Immunol. 3 11 (2002) 1006-1012
297. Oresic K., Noriega V., Andrews L., and Tortorella D. A structural determinant of HCMV US2 dictates the down-regulation of class I MHC molecules. J. Biol. Chem 281 28 (2006) 19395-19406
298. Orth K. Function of the Yersinia effector Yop. J. Curr. Opin. Microbiol. 5 1 (2002) 38-43
299. Orth K., Xu Z., Mudgett M.B., Bao Z.Q., Palmer L.E., Bliska J.B., Mangel W.F., Staskawicz B., and Dixon J.E. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 290 5496 (2000) 1594-1597
300. Ossendorp F., Eggers M., Neisig A., Ruppert T., Groettrup M., Sijts A., Mengede E., Kloetzel P.M., Neefjes J., Koszinowski U., and Melief C. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5 2 (1996) 115-124
301. Pamer E., and Cresswell P. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16 (1998) 323-358
302. Pan Z.Q., Kentsis A., Dias D.C., Yamoah K., and Wu K. Nedd8 on cullin: Building an expressway to protein destruction. Oncogene 23 11 (2004) 1985-1997
303. Parent A.T., Barnes N.Y., Taniguchi Y., Thinakaran G., and Sisodia S.S. Presenilin attenuates receptor-mediated signaling and synaptic function. J. Neurosci. 25 6 (2005) 1540-1549
304. Park B., Kim Y., Shin J., Lee S., Cho K., Fruh K., and Ahn K. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20 1 (2004) 71-85
305. Pazhouhandeh M., Dieterle M., Marrocco K., Lechner E., Berry B., Brault V., Hemmer O., Kretsch T., Richards K.E., Genschik P., and Ziegler-Graff V. F-box-like domain in the polerovirus protein P0 is required for silencing suppressor function. Proc. Natl. Acad. Sci. USA 103 6 (2006) 1994-1999
306. Petroski M.D., and Deshaies R.J. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell. Biol. 6 1 (2005) 9-20
307. Pickart C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70 (2001) 503-533
308. Pickart C.M. Back to the future with ubiquitin. Cell 116 2 (2004) 181-190
309. Pickart C.M., and Eddins M.J. Ubiquitin: Structures, functions, mechanisms. Biochim. Biophys. Acta 1695 1-3 (2004) 55-72
310. Pietra G., Romagnani C., Mazzarino P., Falco M., Millo E., Moretta A., Moretta L., and Mingari M.C. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc. Natl. Acad. Sci. USA 100 19 (2003) 10896-10901
311. Piguet V., Chen Y.L., Mangasarian A., Foti M., Carpentier J.L., and Trono D. Mechanism of Nef-induced CD4 endocytosis: Nef connects CD4 with the mu chain of adaptor complexes. EMBO J. 17 9 (1998) 2472-2481
312. Piguet V., Gu F., Foti M., Demaurex N., Gruenberg J., Carpentier J.L., and Trono D. Nef-induced CD4 degradation: A diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 97 1 (1999) 63-73
313. Piguet V., Schwartz O., Le Gall S., and Trono D. The downregulation of CD4 and MHC-I by primate lentiviruses: A paradigm for the modulation of cell surface receptors. Immunol. Rev. 168 (1999) 51-63
314. Pilon M., Schekman R., and Romisch K. Sec61p mediates export of a misfolded secretory protein from the endoplasmic reticulum to the cytosol for degradation. EMBO J. 16 15 (1997) 4540-4548
315. Pinto A.K., and Hill A.B. Viral interference with antigen presentation to CD8+ T cells: Lessons from cytomegalovirus. Viral Immunol. 18 3 (2005) 434-444
316. Pitha P.M. Multiple effects of interferon on the replication of human immunodeficiency virus type 1. Antiviral Res. 24 2-3 (1994) 205-219
317. Pizarro-Cerda J., and Cossart P. Bacterial adhesion and entry into host cells. Cell 124 4 (2006) 715-727
318. Plemper R.K., Bohmler S., Bordallo J., Sommer T., and Wolf D.H. Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature 388 6645 (1997) 891-895
319. Plemper R.K., Egner R., Kuchler K., and Wolf D.H. Endoplasmic reticulum degradation of a mutated ATP-binding cassette transporter Pdr5 proceeds in a concerted action of Sec61 and the proteasome. J. Biol. Chem. 273 49 (1998) 32848-32856
320. Ploegh H.L. Viral strategies of immune evasion. Science 280 5361 (1998) 248-253
321. Poli G., Orenstein J.M., Kinter A., Folks T.M., and Fauci A.S. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science 244 4904 (1989) 575-577
322. Pornillos O., Alam S.L., Davis D.R., and Sundquist W.I. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat. Struct. Biol. 9 11 (2002) 812-817
323. Pornillos O., Higginson D.S., Stray K.M., Fisher R.D., Garrus J.E., Payne M., He G.P., Wang H.E., Morham S.G., and Sundquist W.I. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. J. Cell Biol. 162 3 (2003) 425-434
324. Prinz W.A., Grzyb L., Veenhuis M., Kahana J.A., Silver P.A., and Rapoport T.A. Mutants affecting the structure of the cortical endoplasmic reticulum in Saccharomyces cerevisiae. J. Cell Biol. 150 3 (2000) 461-474
325. Pulendran B., and Ahmed R. Translating innate immunity into immunological memory: Implications for vaccine development. Cell 124 4 (2006) 849-863
326. Rajagopalan S., and Long E.O. Viral evasion of NK-cell activation. Trends Immunol. 26 8 (2005) 403-405
327. Ramaswamy M., Shi L., Monick M.M., Hunninghake G.W., and Look D.C. Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 30 6 (2004) 893-900
328. Rammensee H.G. Survival of the fitters. Nature 419 6906 (2002) 443-445
329. Rammensee H.G. Immunology: Protein surgery. Nature 427 6971 (2004) 203-204
330. Ravid T., Kreft S.G., and Hochstrasser M. Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways. EMBO J. 25 3 (2006) 533-543
331. Reddehase M.J. Antigens and immunoevasins: Opponents in cytomegalovirus immune surveillance. Nat. Rev. Immunol. 2 11 (2002) 831-844
332. Rehm A., Engelsberg A., Tortorella D., Korner I.J., Lehmann I., Ploegh H.L., and Hopken U.E. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells. J. Virol. 76 10 (2002) 5043-5050
333. Ressing M.E., van Leeuwen D., Verreck F.A., Gomez R., Heemskerk B., Toebes M., Mullen M.M., Jardetzky T.S., Longnecker R., Schilham M.W., Ottenhoff T.H., Neefjes J., et al. Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition. Proc. Natl. Acad. Sci. USA 100 20 (2003) 11583-11588
334. Ressing M.E., van Leeuwen D., Verreck F.A., Keating S., Gomez R., Franken K.L., Ottenhoff T.H., Spriggs M., Schumacher T.N., Hutt-Fletcher L.M., Rowe M., and Wiertz E.J. Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion. J. Virol. 79 2 (2005) 841-852
335. Reyburn H.T., Mandelboim O., Vales-Gomez M., Davis D.M., Pazmany L., and Strominger J.L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386 6624 (1997) 514-517
336. Reyes-Turcu F.E., Horton J.R., Mullally J.E., Heroux A., Cheng X., and Wilkinson K.D. The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin. Cell 124 6 (2006) 1197-1208
337. Richly H., Rape M., Braun S., Rumpf S., Hoege C., and Jentsch S. A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell 120 1 (2005) 73-84
338. Rinaldo Jr. C.R. Modulation of major histocompatibility complex antigen expression by viral infection. Am. J. Pathol. 144 4 (1994) 637-650
339. Ritchie K.J., and Zhang D.E. ISG15: The immunological kin of ubiquitin. Semin. Cell Dev. Biol. 15 2 (2004) 237-246
340. Ritchie K.J., Malakhov M.P., Hetherington C.J., Zhou L., Little M.T., Malakhova O.A., Sipe J.C., Orkin S.H., and Zhang D.E. Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev. 16 17 (2002) 2207-2212
341. Rivett A.J., and Hearn A.R. Proteasome function in antigen presentation: Immunoproteasome complexes, peptide production, and interactions with viral proteins. Curr. Protein Pept. Sci. 5 3 (2004) 153-161
342. Rivett A.J., Mason G.G., Murray R.Z., and Reidlinger J. Regulation of proteasome structure and function. Mol. Biol. Rep. 24 1-2 (1997) 99-102
343. Romagnani C., Pietra G., Falco M., Mazzarino P., Moretta L., and Mingari M.C. HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes. Hum. Immunol. 65 5 (2004) 437-445
344. Romisch K. Endoplasmic reticulum-associated degradation. Annu. Rev. Cell Dev. Biol. 21 (2005) 435-456
345. Romisch K. Cdc48p is UBX-linked to ER ubiquitin ligases. Trends Biochem. Sci. 31 1 (2006) 24-25
346. Roques B.P., Lucas-Soroca E., Chaillet P., Costentin J., and Fournie-Zaluski M.C. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan. Proc. Natl. Acad. Sci. USA 80 11 (1983) 3178-3182
347. Rose J.J., Janvier K., Chandrasekhar S., Sekaly R.P., Bonifacino J.S., and Venkatesan S. CD4 down-regulation by HIV-1 and simian immunodeficiency virus (SIV) Nef proteins involves both internalization and intracellular retention mechanisms. J. Biol. Chem. 280 9 (2005) 7413-7426
348. Ross T.M., Oran A.E., and Cullen B.R. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr. Biol. 9 12 (1999) 613-621
349. Rudolph M.G., and Wilson I.A. The specificity of TCR/pMHC interaction. Curr. Opin. Immunol. 14 1 (2002) 52-65
350. Rumpf S., and Jentsch S. Functional division of substrate processing cofactors of the ubiquitin-selective Cdc48 chaperone. Mol. Cells 21 2 (2006) 261-269
351. Sahara N., Murayama M., Mizoroki T., Urushitani M., Imai Y., Takahashi R., Murata S., Tanaka K., and Takashima A. In vivo evidence of CHIP up-regulation attenuating tau aggregation. J. Neurochem. 94 5 (2005) 1254-1263
352. Sai X., Kawamura Y., Kokame K., Yamaguchi H., Shiraishi H., Suzuki R., Suzuki T., Kawaichi M., Miyata T., Kitamura T., De Strooper B., Yanagisawa K., et al. Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein. J. Biol. Chem. 277 15 (2002) 12915-12920
353. Sakurai A., Yasuda J., Takano H., Tanaka Y., Hatakeyama M., and Shida H. Regulation of human T-cell leukemia virus type 1 (HTLV-1) budding by ubiquitin ligase Nedd4. Microbes Infect. 6 2 (2004) 150-156
354. Salazar-Mather T.P., and Hokeness K.L. Calling in the troops: Regulation of inflammatory cell trafficking through innate cytokine/chemokine networks. Viral Immunol. 16 3 (2003) 291-306
355. Salazar-Mather T.P., and Hokeness K.L. Cytokine and chemokine networks: Pathways to antiviral defense. Curr. Top. Microbiol. Immunol. 303 (2006) 29-46
356. Sanchez D.J., Coscoy L., and Ganem D. Functional organization of MIR2, a novel viral regulator of selective endocytosis. J. Biol. Chem. 277 8 (2002) 6124-6130
357. Saverino D., Fabbi M., Ghiotto F., Merlo A., Bruno S., Zarcone D., Tenca C., Tiso M., Santoro G., Anastasi G., Cosman D., Grossi C.E., et al. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J. Immunol. 165 7 (2000) 3742-3755
358. Saverino D., Ghiotto F., Merlo A., Bruno S., Battini L., Occhino M., Maffei M., Tenca C., Pileri S., Baldi L., Fabbi M., and Bachi A. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J. Immunol. 172 9 (2004) 5629-5637
359. Schauber C., Chen L., Tongaonkar P., Vega I., Lambertson D., Potts W., and Madura K. Rad23 links DNA repair to the ubiquitin/proteasome pathway. Nature 391 6668 (1998) 715-718
360. Scheffner M., Huibregtse J.M., Vierstra R.D., and Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75 3 (1993) 495-505
361. Schlieker C., Korbel G.A., Kattenhorn L.M., and Ploegh H.L. A deubiquitinating activity is conserved in the large tegument protein of the herpesviridae. J. Virol. 79 24 (2005) 15582-15585
362. Schmidt M., Hanna J., Elsasser S., and Finley D. Proteasome-associated proteins: Regulation of a proteolytic machine. Biol. Chem. 386 8 (2005) 725-737
363. Schubert U., Anton L.C., Bacik I., Cox J.H., Bour S., Bennink J.R., Orlowski M., Strebel K., and Yewdell J.W. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72 3 (1998) 2280-2288
364. Schuberth C., and Buchberger A. Membrane-bound Ubx2 recruits Cdc48 to ubiquitin ligases and their substrates to ensure efficient ER-associated protein degradation. Nat. Cell Biol. 7 10 (2005) 999-1006
365. Schuller S., Kugler S., and Goebel W. Suppression of major histocompatibility complex class I and class II gene expression in Listeria monocytogenes-infected murine macrophages. FEMS Immunol. Med. Microbiol. 20 4 (1998) 289-299
366. Schulman B.A., Carrano A.C., Jeffrey P.D., Bowen Z., Kinnucan E.R., Finnin M.S., Elledge S.J., Harper J.W., Pagano M., and Pavletich N.P. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 408 6810 (2000) 381-386
367. Schulze A., Standera S., Buerger E., Kikkert M., van Voorden S., Wiertz E., Koning F., Kloetzel P.M., and Seeger M. The ubiquitin-domain protein HERP forms a complex with components of the endoplasmic reticulum associated degradation pathway. J. Mol. Biol. 354 5 (2005) 1021-1027
368. Schwartz D.C., and Hochstrasser M. A superfamily of protein tags: Ubiquitin, SUMO and related modifiers. Trends Biochem. Sci. 28 6 (2003) 321-328
369. Schwer B., Ren S., Pietschmann T., Kartenbeck J., Kaehlcke K., Bartenschlager R., Yen T.S., and Ott M. Targeting of hepatitis C virus core protein to mitochondria through a novel C-terminal localization motif. J. Virol. 78 15 (2004) 7958-7968
370. Seeger M., Ferrell K., and Dubiel W. The 26S proteasome: A dynamic structure. Mol. Biol. Rep. 24 1-2 (1997) 83-88
371. Selkoe D., and Kopan R. Notch and Presenilin: Regulated intramembrane proteolysis links development and degeneration. Annu. Rev. Neurosci. 26 (2003) 565-597
372. Shackelford J., and Pagano J.S. Tumor viruses and cell signaling pathways: Deubiquitination versus ubiquitination. Mol. Cell. Biol. 24 12 (2004) 5089-5093
373. Shackelford J., and Pagano J.S. Targeting of host-cell ubiquitin pathways by viruses. Essays Biochem. 41 (2005) 139-156
374. Shaffer A.L., Shapiro-Shelef M., Iwakoshi N.N., Lee A.H., Qian S.B., Zhao H., Yu X., Yang L., Tan B.K., Rosenwald A., Hurt E.M., Petroulakis E., et al. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21 1 (2004) 81-93
375. Shamu C.E., Story C.M., Rapoport T.A., and Ploegh H.L. The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate. J. Cell Biol. 147 1 (1999) 45-58
376. Sharrocks A.D. PIAS proteins and transcriptional regulation-more than just SUMO E3 ligases?. Genes Dev. 20 7 (2006) 754-758
377. Shastri N., Cardinaud S., Schwab S.R., Serwold T., and Kunisawa J. All the peptides that fit: The beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol. Rev. 207 (2005) 31-41
378. Shen L., and Rock K.L. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr. Opin. Immunol. 18 1 (2006) 85-91
379. Sievers E., Neumann J., Raftery M., SchOnrich G., Eis-Hubinger A.M., and Koch N. Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules. Immunology 107 1 (2002) 129-135
380. Sisodia S.S., and St George-Hyslop P.H. Gamma-secretase, Notch, Abeta and Alzheimer's disease: Where do the presenilins fit in?. Nat. Rev. Neurosci. 3 4 (2002) 281-290
381. Skehel J.J., and Wiley D.C. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem. 69 (2000) 531-569
382. Smith P.L., Lombardi G., and Foster G.R. Type I interferons and the innate immune response-more than just antiviral cytokines. Mol. Immunol. 42 8 (2005) 869-877
383. Sobko A., Ma H., and Firtel R.A. Regulated SUMOylation and ubiquitination of DdMEK1 is required for proper chemotaxis. Dev. Cell 2 6 (2002) 745-756
384. Soboleva T.A., and Baker R.T. Deubiquitinating enzymes: Their functions and substrate specificity. Curr. Protein Pept. Sci. 5 3 (2004) 191-200
385. Sol-Foulon N., Moris A., Nobile C., Boccaccio C., Engering A., Abastado J.P., Heard J.M., van Kooyk Y., and Schwartz O. HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread. Immunity 16 1 (2002) 145-155
386. Song B.L., Sever N., and DeBose-Boyd R.A. Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase. Mol. Cells 19 6 (2005) 829-840
387. Sorin M., and Kalpana G.V. Dynamics of virus-host interplay in HIV-1 replication. Curr. HIV Res. 4 2 (2006) 117-130
388. Spriggs M.K., Armitage R.J., Comeau M.R., Strockbine L., Farrah T., Macduff B., Ulrich D., Alderson M.R., Mullberg J., and Cohen J.I. The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. J. Virol. 70 8 (1996) 5557-5563
389. Srisatjaluk R., Kotwal G.J., Hunt L.A., and Justus D.E. Modulation of gamma interferon-induced major histocompatibility complex class II gene expression by Porphyromonas gingivalis membrane vesicles. Infect. Immun. 70 3 (2002) 1185-1192
390. Stern L.J., Potolicchio I., and Santambrogio L. MHC class II compartment subtypes: Structure and function. Curr. Opin. Immunol. 18 1 (2006) 64-69
391. Stevenson P.G., Efstathiou S., Doherty P.C., and Lehner P.J. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc. Natl. Acad. Sci. USA 97 15 (2000) 8455-8460
392. Stockwin L.H., McGonagle D., Martin I.G., and Blair G.E. Dendritic cells: Immunological sentinels with a central role in health and disease. Immunol. Cell Biol. 78 2 (2000) 91-102
393. Strehl B., Seifert U., Kruger E., Heink S., Kuckelkorn U., and Kloetzel P.M. Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing. Immunol. Rev. 207 (2005) 19-30
394. Stuchell M.D., Garrus J.E., Muller B., Stray K.M., Ghaffarian S., McKinnon R., Krausslich H.G., Morham S.G., and Sundquist W.I. The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding. J. Biol. Chem. 279 34 (2004) 36059-36071
395. Stumptner-Cuvelette P., Morchoisne S., Dugast M., Le Gall S., Raposo G., Schwartz O., and Benaroch P. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. USA 98 21 (2001) 12144-12149
396. Stumptner-Cuvelette P., Jouve M., Helft J., Dugast M., Glouzman A.S., Jooss K., Raposo G., and Benaroch P. Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: Potential role of phosphatidylinositol 3-kinase. Mol. Biol. Cell 14 12 (2003) 4857-4870
397. Suzuki R., Sakamoto S., Tsutsumi T., Rikimaru A., Tanaka K., Shimoike T., Moriishi K., Iwasaki T., Mizumoto K., Matsuura Y., Miyamura T., and Suzuki T. Molecular determinants for subcellular localization of hepatitis C virus core protein. J. Virol. 79 2 (2005) 1271-1281
398. Suzuki T., Park H., Hollingsworth N.M., Sternglanz R., and Lennarz W.J. PNG1, a yeast gene encoding a highly conserved peptide: N-glycanase. J. Cell Biol. 149 5 (2000) 1039-1052
399. Swanson R., Locher M., and Hochstrasser M. A conserved ubiquitin ligase of the nuclear envelope/endoplasmic reticulum that functions in both ER-associated and Matalpha2 repressor degradation. Genes Dev. 15 20 (2001) 2660-2674
400. Swigut T., Shohdy N., and Skowronski J. Mechanism for down-regulation of CD28 by Nef. EMBO J. 20 7 (2001) 1593-1604
401. Tarasova N.I., Seth R., Tarasov S.G., Kosakowska-Cholody T., Hrycyna C.A., Gottesman M.M., and Michejda C.J. Transmembrane inhibitors of P-glycoprotein, an ABC transporter. J. Med. Chem. 48 11 (2005) 3768-3775
402. Taxis C., Vogel F., and Wolf D.H. ER-golgi traffic is a prerequisite for efficient ER degradation. Mol. Biol. Cell. 13 6 (2002) 1806-1818
403. Teckman J.H., and Perlmutter D.H. The endoplasmic reticulum degradation pathway for mutant secretory proteins alpha1-antitrypsin Z and S is distinct from that for an unassembled membrane protein. J. Biol. Chem. 271 22 (1996) 13215-13220
404. Thoms S. Cdc48 can distinguish between native and non-native proteins in the absence of cofactors. FEBS Lett. 520 1-3 (2002) 107-110
405. Tokarz S., Berset C., La Rue J., Friedman K., Nakayama K., Zhang D.E., and Lanker S. The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase. J. Biol. Chem. 279 45 (2004) 46424-46430
406. Tomasec P., Braud V.M., Rickards C., Powell M.B., McSharry B.P., Gadola S., Cerundolo V., Borysiewicz L.K., McMichael A.J., and Wilkinson G.W. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287 5455 (2000) 1031
407. Tomasec P., Wang E.C., Davison A.J., Vojtesek B., Armstrong M., Griffin C., McSharry B.P., Morris R.J., Llewellyn-Lacey S., Rickards C., Nomoto A., Sinzger C., et al. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus. Nat. Immunol. 6 2 (2005) 181-188
408. Tomazin R., Boname J., Hegde N.R., Lewinsohn D.M., Altschuler Y., Jones T.R., Cresswell P., Nelson J.A., Riddell S.R., and Johnson D.C. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat. Med. 5 9 (1999) 1039-1043
409. Tortorella D., Gewurz B.E., Furman M.H., Schust D.J., and Ploegh H.L. Viral subversion of the immune system. Annu. Rev. Immunol. 18 (2000) 861-926
410. Tzfira T., Li J., Lacroix B., and Citovsky V. Agrobacterium T-DNA integration: Molecules and models. Trends Genet. 20 8 (2004) 375-383
411. Tzfira T., Vaidya M., and Citovsky V. Involvement of targeted proteolysis in plant genetic transformation by Agrobacterium. Nature 431 7004 (2004) 87-92
412. Ulane C.M., and Horvath C.M. Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304 2 (2002) 160-166
413. Ulane C.M., Kentsis A., Cruz C.D., Parisien J.P., Schneider K.L., and Horvath C.M. Composition and assembly of STAT-targeting ubiquitin ligase complexes: Paramyxovirus V protein carboxyl terminus is an oligomerization domain. J. Virol. 79 16 (2005) 10180-10189
414. Ulane C.M., Rodriguez J.J., Parisien J.P., and Horvath C.M. STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling. J. Virol. 77 11 (2003) 6385-6393
415. Ulbrecht M., Martinozzi S., Grzeschik M., Hengel H., Ellwart J.W., Pla M., and Weiss E.H. Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 164 10 (2000) 5019-5022
416. Van den Eynde B.J., and Morel S. Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome. Curr. Opin. Immunol. 13 2 (2001) 147-153
417. Varshavsky A. Regulated protein degradation. Trends Biochem. Sci. 30 6 (2005) 283-286
418. Vashist S., and Ng D.T. Misfolded proteins are sorted by a sequential checkpoint mechanism of ER quality control. J. Cell Biol. 165 1 (2004) 41-52
419. Vashist S., Kim W., Belden W.J., Spear E.D., Barlowe C., and Ng D.T. Distinct retrieval and retention mechanisms are required for the quality control of endoplasmic reticulum protein folding. J. Cell Biol. 155 3 (2001) 355-368
420. Villadangos J.A., Bryant R.A., Deussing J., Driessen C., Lennon-Dumenil A.M., Riese R.J., Roth W., Saftig P., Shi G.P., Chapman H.A., Peters C., and Ploegh H.L. Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172 (1999) 109-120
421. von Boehmer H. Shaping the T cell repertoire. J. Immunol. 176 1 (2006) 3-4
422. von Heijne G. Signal sequences. The limits of variation. J. Mol. Biol. 184 1 (1985) 99-105
423. Wagner M., Gutermann A., Podlech J., Reddehase M.J., and Koszinowski U.H. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J. Exp. Med. 196 6 (2002) 805-816
424. Wang J., Beher D., Nyborg A.C., Shearman M.S., Golde T.E., and Goate A. C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation. J. Neurochem. 96 1 (2006) 218-227
425. Wang J., Loveland A.N., Kattenhorn L.M., Ploegh H.L., and Gibson W. High-molecular-weight protein (pUL48) of human cytomegalovirus is a competent deubiquitinating protease: Mutant viruses altered in its active-site cysteine or histidine are viable. J. Virol. 80 12 (2006) 6003-6012
426. Wang R., Tang P., Wang P., Boissy R.E., and Zheng H. Regulation of tyrosinase trafficking and processing by presenilins: Partial loss of function by familial Alzheimer's disease mutation. Proc. Natl. Acad. Sci. USA 103 2 (2006) 353-358
427. Wang X., Lybarger L., Connors R., Harris M.R., and Hansen T.H. Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class I and the peptide-loading complex. J. Virol. 78 16 (2004) 8673-8686
428. Wang X., Connors R., Harris M.R., Hansen T.H., and Lybarger L. Requirements for the selective degradation of endoplasmic reticulum-resident major histocompatibility complex class I proteins by the viral immune evasion molecule mK3. J. Virol. 79 7 (2005) 4099-4108
429. Wang X., Ye Y., Lencer W., and Hansen T.H. The viral E3 ubiquitin ligase mK3 uses the Derlin/p97 endoplasmic reticulum-associated degradation pathway to mediate down-regulation of major histocompatibility complex class I proteins. J. Biol. Chem. 281 13 (2006) 8636-8644
430. Ward C.L., Omura S., and Kopito R.R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83 1 (1995) 121-127
431. Weihofen A., Binns K., Lemberg M.K., Ashman K., and Martoglio B. Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296 5576 (2002) 2215-2218
432. Werner E.D., Brodsky J.L., and McCracken A.A. Proteasome-dependent endoplasmic reticulum-associated protein degradation: An unconventional route to a familiar fate. Proc. Natl. Acad. Sci. USA 93 24 (1996) 13797-13801
433. Wiertz E.J., Jones T.R., Sun L., Bogyo M., Geuze H.J., and Ploegh H.L. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84 5 (1996) 769-779
434. Wiertz E.J., Tortorella D., Bogyo M., Yu J., Mothes W., Jones T.R., Rapoport T.A., and Ploegh H.L. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature 384 6608 (1996) 432-438
435. Wilkinson C.R., Seeger M., Hartmann-Petersen R., Stone M., Wallace M., Semple C., and Gordon C. Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat. Cell Biol. 3 10 (2001) 939-943
436. Wills M.R., Ashiru O., Reeves M.B., Okecha G., Trowsdale J., Tomasec P., Wilkinson G.W., Sinclair J., and Sissons J.G. Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J. Immunol. 175 11 (2005) 7457-7465
437. Wilson C.A., Murphy D.D., Giasson B.I., Zhang B., Trojanowski J.Q., and Lee V.M. Degradative organelles containing mislocalized alpha- and beta-synuclein proliferate in presenilin-1 null neurons. J. Cell Biol. 165 3 (2004) 335-346
438. Winston J.T., Koepp D.M., Zhu C., Elledge S.J., and Harper J.W. A family of mammalian F-box proteins. Curr. Biol. 9 20 (1999) 1180-1182
439. Woodman P.G. p97, a protein coping with multiple identities. J. Cell Sci. 116 Pt. 21 (2003) 4283-4290
440. Wu J.T., Lin H.C., Hu Y.C., and Chien C.T. Neddylation and deneddylation regulate Cul1 and Cul3 protein accumulation. Nat. Cell Biol. 7 10 (2005) 1014-1020
441. Xia W., and Wolfe M.S. Intramembrane proteolysis by presenilin and presenilin-like proteases. J. Cell Sci. 116 Pt 14 (2003) 2839-2844
442. Yamamoto A., Friedlein A., Imai Y., Takahashi R., Kahle P.J., and Haass C. Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity. J. Biol. Chem. 280 5 (2005) 3390-3399
443. Yang M., Omura S., Bonifacino J.S., and Weissman A.M. Novel aspects of degradation of T cell receptor subunits from the endoplasmic reticulum (ER) in T cells: Importance of oligosaccharide processing, ubiquitination, and proteasome-dependent removal from ER membranes. J. Exp. Med. 187 6 (1998) 835-846
444. Yasuda J., Nakao M., Kawaoka Y., and Shida H. Nedd4 regulates egress of Ebola virus-like particles from host cells. J. Virol. 77 18 (2003) 9987-9992
445. Ye Y., Meyer H.H., and Rapoport T.A. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414 6864 (2001) 652-656
446. Ye Y., Meyer H.H., and Rapoport T.A. Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: Dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol. 162 1 (2003) 71-84
447. Ye Y., Shibata Y., Yun C., Ron D., and Rapoport T.A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429 6994 (2004) 841-847
448. Ye Y., Shibata Y., Kikkert M., van Voorden S., Wiertz E., and Rapoport T.A. Inaugural Article: Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc. Natl. Acad. Sci. USA 102 40 (2005) 14132-14138
449. Yewdell J.W., and Hill A.B. Viral interference with antigen presentation. Nat. Immunol. 3 11 (2002) 1019-1025
450. Yewdell J.W., Schubert U., and Bennink J.R. At the crossroads of cell biology and immunology: DRiPs and other sources of peptide ligands for MHC class I molecules. J. Cell. Sci. 114 Pt 5 (2001) 845-851
451. Yin Y., Manoury B., and Fahraeus R. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301 5638 (2003) 1371-1374
452. Yoshida Y. A novel role for N-glycans in the ERAD system. J. Biochem. (Tokyo) 134 2 (2003) 183-190
453. Yoshida Y., Chiba T., Tokunaga F., Kawasaki H., Iwai K., Suzuki T., Ito Y., Matsuoka K., Yoshida M., Tanaka K., and Tai T. E3 ubiquitin ligase that recognizes sugar chains. Nature 418 6896 (2002) 438-442
454. Yoshida Y., Tokunaga F., Chiba T., Iwai K., Tanaka K., and Tai T. Fbs2 is a new member of the E3 ubiquitin ligase family that recognizes sugar chains. J. Biol. Chem. 278 44 (2003) 43877-43884
455. Yu X., Yu Y., Liu B., Luo K., Kong W., Mao P., and Yu X.F. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302 5647 (2003) 1056-1060
456. Yu Y.Y., Harris M.R., Lybarger L., Kimpler L.A., Myers N.B., Virgin V H.W., and Hansen T.H. Physical association of the K3 protein of gamma-2 herpesvirus 68 with major histocompatibility complex class I molecules with impaired peptide and beta(2)-microglobulin assembly. J. Virol. 76 6 (2002) 2796-2803
457. Yuan W., and Krug R.M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20 3 (2001) 362-371
458. Yuan W., Aramini J.M., Montelione G.T., and Krug R.M. Structural basis for ubiquitin-like ISG 15 protein binding to the NS1 protein of influenza B virus: A protein-protein interaction function that is not shared by the corresponding N-terminal domain of the NS1 protein of influenza A virus. Virology 304 2 (2002) 291-301
459. Zamore P.D. Plant RNAi: How a viral silencing suppressor inactivates siRNA. Curr. Biol. 14 5 (2004) R198-R200
460. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., and Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424 6944 (2003) 94-98
461. Zhang X., Shaw A., Bates P.A., Newman R.H., Gowen B., Orlova E., Gorman M.A., Kondo H., Dokurno P., Lally J., Leonard G., Meyer H., et al. Structure of the AAA ATPase p97. Mol. Cells 6 6 (2000) 1473-1484
462. Zhao C., Beaudenon S.L., Kelley M.L., Waddell M.B., Yuan W., Schulman B.A., Huibregtse J.M., and Krug R.M. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc. Natl. Acad. Sci. USA 101 20 (2004) 7578-7582
463. Zheng N., Schulman B.A., Song L., Miller J.J., Jeffrey P.D., Wang P., Chu C., Koepp D.M., Elledge S.J., Pagano M., Conaway R.C., Conaway J.W., et al. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416 6882 (2002) 703-709
464. Zhong G., Fan T., and Liu L. Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J. Exp. Med. 189 12 (1999) 1931-1938
465. Zhou H., Monack D.M., Kayagaki N., Wertz I., Yin J., Wolf B., and Dixit V.M. Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J. Exp. Med. 202 10 (2005) 1327-1332
466. Zimmermann A., Trilling M., Wagner M., Wilborn M., Bubic I., Jonjic S., Koszinowski U., and Hengel H. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J. Exp. Med. 201 10 (2005) 1543-1553
467. Zingoni A., Sornasse T., Cocks B.G., Tanaka Y., Santoni A., and Lanier L.L. NK cell regulation of T cell-mediated responses. Mol. Immunol. 42 4 (2005) 451-454
468. Zou W., and Zhang D.E. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 281 7 (2006) 3989-3994